BONE RESPONSE TO SOY ISOFLAVONES IN WOMEN

加州戴维斯大学（UC Davis）与退伍军人事务部北方加州卫生保健系统（VANCHCS）合作，提出了一个综合临床研究中心，以提供一个集中的基础设施，以支持临床/转化研究，并扩大临床研究培训和职业发展计划。加州大学戴维斯分校有能力承担这一雄心勃勃的提议;主要资源已经分配给临床研究，作为重点五年计划的一部分，以创建一个充满活力和活力的临床研究社区。加州大学戴维斯分校从众多大学招募了经验丰富的临床研究人员，目前正在招募一名新的临床研究助理院长，学校的领导层完全致力于GCRC的成功。一个指定的7,500平方英尺的GCRC单位是新建的萨克拉门托VA医疗中心的一部分，VANCHCS和加州大学戴维斯分校已经 提供资源来开发这个设施。加州大学戴维斯分校和VANCHCS提供了超过350万美元来创建GCRC。其中，250万美元用于建造GCRC设施，100万美元用于支持开发阶段。因此，GCRC的基础设施已经到位，GCRC的领导人也已经确定。加州大学戴维斯分校赞助研究的快速增长，以及对临床和 转化研究使拟议的GCRC成为实现加州大学戴维斯分校和VANCHCS雄心勃勃的目标的必要和重要组成部分，以创建一个拥有大量研究人员的尖端临床研究企业。提交的63份方案涉及住院、门诊、实验室、生物统计、营养、患者安全和信息学 支持以病人为中心的研究。他们代表了广泛的调查人员和研究领域。反映在加州大学戴维斯分校的科学实力，大多数的协议已经由研究人员在四个领先的，广泛定义和包容性的重点领域开发;传染病，癌症，血管生物学/代谢和神经科学。这些领域已被加州大学戴维斯分校卫生系统领导层确定为主要领域， 未来的研究增长。除了这些领域，GCRC还促进了与代表基础科学的研究人员，所有领先的临床中心以及医学院以外的领域（如营养和工程）的合作。我们将继续促进和协助来自各个领域的临床研究人员。指导和教育计划是GCRC的重中之重，并将作为一个关键的催化剂，以扩大和集中在加州大学戴维斯分校已经到位的许多现有资源和举措。我们渴望以最高标准的患者护理，道德，科学严谨性，安全性和监管合规性进行以患者为导向的研究，GCRC是实现这些目标的重要组成部分。

The University of California Davis (UC Davis) in collaboration with the Veterans Affairs Northern California Health Care System (VANCHCS) proposes a General Clinical Research Center to provide a centralized infrastructure to support clinical/translational research and to expand clinical research training and career development programs. UC Davis is well positioned to undertake this ambitious proposal; major resources are already allocated to clinical research as part of a focused five-year plan to create a vibrant and dynamic clinical research community. UC Davis has recruited experienced clinical researchers from a multitude of universities, is currently recruiting a new Assistant Dean for Clinical Research, and the leadership of the school is fully committed to the success of the GCRC. A designated 7,500 square feet GCRC unit is a part of the newly constructed Sacramento VA Medical Center, and VANCHCS and UC Davis have provided resources to develop this facility. UC Davis and the VANCHCS have provided more than $3.5 million to create the GCRC. Of this amount, $2.5 million represent cost for construction of the GCRC facility, and $1 million represents support for the development phase. Thus, the infrastructure for the GCRC is already in place, and GCRC leaders have been identified. The rapid growth in sponsored research at UC Davis together with the strategic focus on clinical and translational research makes the proposed GCRC a necessary and essential component to achieve the ambitious goals of UC Davis and VANCHCS to create a cutting edge clinical research enterprise with a critical mass of investigators. The 63 submitted protocols use inpatient, outpatient, laboratory, biostatistical, nutrition, patient safety and informatics support for patient-oriented research. They represent a wide spectrum of investigators and research areas. Reflecting the scientific strengths at UC Davis, the majority of the protocols have been developed by investigators in four leading, broadly defined and inclusive focus areas; Infectious Disease, Cancer, Vascular Biology/Metabolism, and Neuroscience. These areas have been identified by the UC Davis Health System leadership as principal areas for future research growth. Beyond these areas, the GCRC has fostered campus-wide collaborations with investigators representing basic sciences, all the leading clinical centers, and areas outside the medical school such as nutrition and engineering. We will continue to facilitate and assist clinical researchers from all areas. Mentoring and education plans are a top priority of the GCRC, and will serve as a critical catalyst to expand and focus the many existing resources and initiatives already in place at UC Davis. We aspire to perform patient-oriented research with the highest standards of patient care, ethics, scientific rigor, safety and regulatory compliance, and the GCRC is an essential component to achieve these goals.